Phosphate removal model: An observational study of low-flux dialyzers in conventional hemodialysis therapy

Hemodialysis International

Volumn 16, Issue 3, 2012, Pages 363-376

  Wang, Mengjing ^a   Li, Haiming ^a   Liao, Huimin ^a   Yu, Yongfu ^a   You, Li ^a   Zhu, Jianguo ^a   Huang, Bihong ^a   Yuan, Li ^a   Hao, Chuanming ^a   Chen, Jing ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Dialytic phosphate removal; Hemodialysis; Hyperphosphatemia; Kinetic modeling

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CARBON DIOXIDE; PARATHYROID HORMONE; PHOSPHATE; POLYSULFONE; POTASSIUM;

ADULT; AGE; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL KIDNEY; BLOOD FLOW VELOCITY; BODY WEIGHT; CARBON DIOXIDE BLOOD LEVEL; DIALYSATE; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; ULTRAFILTRATION;

DIALYSIS SOLUTIONS; FEMALE; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PHOSPHATES; RENAL DIALYSIS;

EID: 84863435242     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2012.00678.x     Document Type: Article

References (54)

1. Farrow EG, White KE. Recent advances in renal phosphate handling. Nat Rev Nephrol. 2010; 6:207-217.
2. Silver J, Naveh-Many T. Phosphate and the parathyroid. Kidney Int. 2009; 75:898-905.
3. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15:2208-2218.
4. Wald R, Sarnak MJ, Tighiouart H, etal. Disordered mineral metabolism in hemodialysis patients: An analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2008; 52:531-540.
5. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2008; 19:213-216.
6. Amann K, Tornig J, Kugel B, etal. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int. 2003; 63:1296-1301.
7. Sampathkumar K. Niacin and analogs for phosphate control in dialysis-Perspective from a developing country. Int Urol Nephrol. 2009; 41:913-918.
8. Afifi A, El-Sayed H, El-Setouhi M, Ahmed H, Khalifa N. Hyperphosphatemia among end-stage renal disease patients in developing countries: A forgotten issue? Hemodial Int. 2005; 9:409-415.
9. Tentori F. Mineral and bone disorder and outcomes in hemodialysis patients: Results from the DOPPS. Semin Dial. 2010; 23:10-14.
10. Kuhlmann MK. Management of hyperphosphatemia. Hemodial Int. 2006; 10:338-345.
11. Schucker JJ, Ward KE. Hyperphosphatemia and phosphate binders. Am J Health Syst Pharm. 2005; 62:2355-2361.
12. Argiles A, Ficheux A, Thomas M, etal. Precise quantification of dialysis using continuous sampling of spent dialysate and total dialysate volume measurement. Kidney Int. 1997; 52:530-537.
13. Gutzwiller JP, Schneditz D, Huber AR, Schindler C, Gutzwiller F, Zehnder CE. Estimating phosphate removal in haemodialysis: An additional tool to quantify dialysis dose. Nephrol Dial Transplant. 2002; 17:1037-1044.
14. Gotch FA, Panlilio F, Sergeyeva O, etal. A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif. 2003; 21:51-57.
15. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol. 1993; 4:1205-1213.
16. Rouphael Y, Mouneimne AH, Ismail A, etal. Modeling individual leaf area of rose (Rosa hybrida L.) based on leaf length and width measurement. Photosynthetica. 2010; 48:9-15.
17. De Nicola L, Minutolo R, Conte G. Is the type of hemodialysis important to control serum phosphate? Blood Purif. 2006; 24:299-300.
18. Perl J, Chan CT. Home hemodialysis, daily hemodialysis, and nocturnal hemodialysis: Core Curriculum 2009. Am J Kidney Dis. 2009; 54:1171-1184.
19. Cravedi P, Ruggenenti P, Mingardi G, Sghirlanzoni MC, Remuzzi G. Thrice-weekly in-center nocturnal hemodialysis: An effective strategy to optimize chronic dialysis therapy. Int J Artif Organs. 2009; 32:12-19.
20. Ayus JC, Achinger SG, Mizani MR, etal. Phosphorus balance and mineral metabolism with 3h daily hemodialysis. Kidney Int. 2007; 71:336-342.
21. Troidle L, Finkelstein F, Hotchkiss M, Leypoldt JK. Enhanced solute removal with intermittent, in-center, 8-hour nocturnal hemodialysis. Hemodial Int. 2009; 13:487-491.
22. Pohlmeier R, Vienken J. Phosphate removal and hemodialysis conditions. Kidney Int Suppl. 2001; 78:S190-S194.
23. Achinger SG, Ayus JC. The role of daily dialysis in the control of hyperphosphatemia. Kidney Int Suppl. 2005; 95:S28-S32.
24. Kuhlmann MK. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif. 2010; 29:137-144.
25. Harris DC, Yuill E, Chesher DW. Correcting acidosis in hemodialysis: Effect on phosphate clearance and calcification risk. J Am Soc Nephrol. 1995; 6:1607-1612.
26. Leypoldt JK. Kinetics of beta2-microglobulin and phosphate during hemodialysis: Effects of treatment frequency and duration. Semin Dial. 2005; 18:401-408.
27. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int. 2002; 61:655-667.
28. Leelahavanichkul A, Areepium N, Vadcharavivad S, etal. Pharmacokinetics of sirolimus in Thai healthy volunteers. J Med Assoc Thai. 2005; 88(Suppl 4):157-162.
29. Gotch FA, Panlilio F, Sergeyeva O, etal. Effective diffusion volume flow rates (Qe) for urea, creatinine, and inorganic phosphorous (Qeu, Qecr, QeiP) during hemodialysis. Semin Dial. 2003; 16:474-476.
30. Hauk M, Kuhlmann MK, Riegel W, Kohler H. In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients. Am J Kidney Dis. 2000; 35:105-111.
31. Gutzwiller JP, Schneditz D, Huber AR, Schindler C, Garbani E, Zehnder CE. Increasing blood flow increases kt/V (urea) and potassium removal but fails to improve phosphate removal. Clin Nephrol. 2003; 59:130-136.
32. Jindal KK, McDougall J, Woods B, Nowakowski L, Goldstein MB. A study of the basic principles determining the performance of several high-flux dialyzers. Am J Kidney Dis. 1989; 14:507-511.
33. Zucchelli P, Santoro A. Inorganic phosphate removal during different dialytic procedures. Int J Artif Organs. 1987; 10:173-178.
34. Kramer BK, Pickert A, Hohmann C, etal. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes. Int J Artif Organs. 1992; 15:408-412.
35. Gallar P, Ortiz M, Ortega O, etal. Factors which influence phosphorus removal in hemodialysis. Nefrologia. 2007; 27:46-52.
36. DeSoi CA, Umans JG. Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol. 1993; 4:1214-1218.
37. Messa P, Gropuzzo M, Cleva M, etal. Behaviour of phosphate removal with different dialysis schedules. Nephrol Dial Transplant. 1998; 13(SUPPL. 6):43-48.
38. Albalate M, de la Piedra C, Fernandez C, etal. Association between phosphate removal and markers of bone turnover in haemodialysis patients. Nephrol Dial Transplant. 2006; 21:1626-1632.
39. Mandolfo S, Malberti F, Imbasciati E, Cogliati P, Gauly A. Impact of blood and dialysate flow and surface on performance of new polysulfone hemodialysis dialyzers. Int J Artif Organs. 2003; 26:113-120.
40. Tonelli M, Wang W, Hemmelgarn B, Lloyd A, Manns B. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients. Am J Kidney Dis. 2009; 54:1108-1115.
41. Vaithilingam I, Polkinghorne KR, Atkins RC, Kerr PG. Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis. 2004; 43:85-89.
42. Zehnder C, Gutzwiller JP, Renggli K. Hemodiafiltration-A new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol. 1999; 52:152-159.
43. Lindsay RM, Alhejaili F, Nesrallah G, etal. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis. 2003; 42(SUPPL. 1):24-29.
44. Albalate M, Fernandez C, Lopez MD, etal. Can we increase phosphate removal with conventional hemodialysis? Nefrologia. 2003; 23:520-527.
45. Kossmann RJ, Gonzales A, Callan R, Ahmad S. Increased efficiency of hemodialysis with citrate dialysate: A prospective controlled study. Clin J Am Soc Nephrol. 2009; 4:1459-1464.
46. Pogglitsch H, Petek W, Ziak E, Sterz F, Holzer H. Phosphorus kinetics during haemodialysis and haemofiltration. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985; 21:461-468.
47. Ziolko M, Pietrzyk JA, Grabska-Chrzastowska J. Accuracy of hemodialysis modeling. Kidney Int. 2000; 57:1152-1163.
48. Ronco C, Clark W. Factors affecting hemodialysis and peritoneal dialysis efficiency. Semin Dial. 2001; 14:257-262.
49. Fischbach M, Hamel G, Simeoni U, Geisert J. Phosphate dialytic removal: Enhancement of phosphate cellular clearance by biofiltration (with acetate-free buffer dialysate). Nephron. 1992; 62:155-160.
50. Fukagawa NK, Bandini LG, Dietz WH, Young JB. Effect of age on body water and resting metabolic rate. J Gerontol A Biol Sci Med Sci. 1996; 51:71-73.
51. Lornoy W, De Meester J, Becaus I, Billiouw JM, Van Malderen PA, Van Pottelberge M. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients. J Ren Nutr. 2006; 16:47-53.
52. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: Global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005; 20:2587-2593.
53. Bamgboye EL. Hemodialysis: Management problems in developing countries, with Nigeria as a surrogate. Kidney Int SUPPL. 2003; 63:S93-S95.
54. Guida B, Piccoli A, Trio R, etal. Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia. Nutr Metab Cardiovasc Dis. 2010; 21:879-884.